Symptoms and diagnosis
Home
Usage examples
Diseases
Therapies
Medicinal plants
Frequent searches
Medical search
Health topics
Healthy weight
Medical dictionary
Health sites
Questions and answers
Advertisement
Astellas-Basileas Isavuconazole Accepted for EU Review
Astellas Pharma, Inc. (ALPMY) and partner Basilea Pharmaceutica's isavuconazole has been accepted for review in the EU. The companies are looking to get isavuconazole approved in the EU for the treatment of invasive aspergillosis and mucormycosis ...
Zacks.com - Thu, 21 Aug 2014 13:36

What You Missed From Regulatory Agencies Recently – August 18-28, 2014
Should the application be accepted, the drug would be indicated for the treatment of invasive aspergillosis and mucormycosis (zygomycosis) in adults and would be available in the 28 member states of the EU, as well as in Iceland, Liechtenstein, and Norway.
Pharmaceutical Online (press release) - Thu, 28 Aug 2014 07:03

European Medicines Agency accepts Basilea's isavuconazole Marketing ...
Mucormycosis (also known as zygomycosis) is an often lethal fungal infection caused by certain emerging molds. Mucormycosis is associated with high morbidity and mortality rates in immunocompromised patients such as patients undergoing chemotherapy ...
Wall Street Journal - Wed, 20 Aug 2014 22:26

Astellas-Basilea's Isavuconazole Accepted for EU Review - Analyst Blog
Astellas Pharma, Inc. ( ALPMY ) and partner Basilea Pharmaceutica's isavuconazole has been accepted for review in the EU. The companies are looking to get isavuconazole approved in the EU for the treatment of invasive aspergillosis and mucormycosis ...
NASDAQ - Thu, 21 Aug 2014 14:00

EMA agrees to review Basilea's isavuconazole marketing authorization application
Pharmaceutical Business Review - Fri, 22 Aug 2014 08:11

GNW-News: Europäische Arzneimittelagentur nimmt Basileas Zulassungsantrag ...
Emerging invasive zygomycosis in a tertiary care center: epidemiology and associated risk factors. International Journal of Infectious Diseases 2010 (14S), e100-e103 6 J. Wingard. Zygomycosis: Epidemiology and treatment options. Proceedings 2006 (6) ...
Finanztreff - Wed, 20 Aug 2014 22:39

"It emerged last night that Nils Albert, a partner in private equity giant TPG ...
Basilea's MAA seeks approval of isavuconazole for the treatment of invasive aspergillosis and mucormycosis (zygomycosis) in adults. weiterlesen ... presseportal.de schreibt weiter: Notification concerning transactions by persons performing managerial ...
Ad-Hoc-News (Pressemitteilung) - Sat, 23 Aug 2014 14:00

Fears of volcano eruption increase as Met Office register 1000 small ...
Basilea's MAA seeks approval of isavuconazole for the treatment of invasive aspergillosis and mucormycosis (zygomycosis) in adults. weiterlesen ... Artikel von rss.wn.com: Thousands of small earthquakes have rattled Iceland's Bardarbunga volcano over ...
Ad-Hoc-News (Pressemitteilung) - Thu, 21 Aug 2014 04:48

"There are some phone calls which brighten up your day. "
Basilea's MAA seeks approval of isavuconazole for the treatment of invasive aspergillosis and mucormycosis (zygomycosis) in adults. weiterlesen ... latimes.com: Vampire Bill Compton (Stephen Moyer) reveals why he won?t accept a lifesaving antidote on ?
Ad-Hoc-News (Pressemitteilung) - Thu, 21 Aug 2014 08:56


1  2  3  4    ->

Last update: September 2014
Statistics


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014
Statistics